WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
98.69
+7.07 (7.72%)
Jul 29, 2025, 3:00 PM CST
7.72%
Market Cap282.17B
Revenue (ttm)41.48B
Net Income (ttm)13.77B
Shares Out2.85B
EPS (ttm)4.01
PE Ratio21.71
Forward PE21.27
Dividend0.98 (0.99%)
Ex-Dividend DateMay 21, 2025
Volume94,014,709
Average Volume42,856,259
Open93.45
Previous Close91.62
Day's Range90.70 - 99.76
52-Week Range36.86 - 99.74
Beta0.76
RSI90.26
Earnings DateJul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.